367 related articles for article (PubMed ID: 24293234)
1. Withaferin A inhibits experimental epithelial-mesenchymal transition in MCF-10A cells and suppresses vimentin protein level in vivo in breast tumors.
Lee J; Hahm ER; Marcus AI; Singh SV
Mol Carcinog; 2015 Jun; 54(6):417-29. PubMed ID: 24293234
[TBL] [Abstract][Full Text] [Related]
2. Benzyl isothiocyanate inhibits epithelial-mesenchymal transition in cultured and xenografted human breast cancer cells.
Sehrawat A; Singh SV
Cancer Prev Res (Phila); 2011 Jul; 4(7):1107-17. PubMed ID: 21464039
[TBL] [Abstract][Full Text] [Related]
3. Withaferin a suppresses estrogen receptor-α expression in human breast cancer cells.
Hahm ER; Lee J; Huang Y; Singh SV
Mol Carcinog; 2011 Aug; 50(8):614-24. PubMed ID: 21432907
[TBL] [Abstract][Full Text] [Related]
4. Autophagy fails to alter withaferin A-mediated lethality in human breast cancer cells.
Hahm ER; Singh SV
Curr Cancer Drug Targets; 2013 Jul; 13(6):640-50. PubMed ID: 23607597
[TBL] [Abstract][Full Text] [Related]
5. Withaferin A causes FOXO3a- and Bim-dependent apoptosis and inhibits growth of human breast cancer cells in vivo.
Stan SD; Hahm ER; Warin R; Singh SV
Cancer Res; 2008 Sep; 68(18):7661-9. PubMed ID: 18794155
[TBL] [Abstract][Full Text] [Related]
6. Withaferin A inhibits activation of signal transducer and activator of transcription 3 in human breast cancer cells.
Lee J; Hahm ER; Singh SV
Carcinogenesis; 2010 Nov; 31(11):1991-8. PubMed ID: 20724373
[TBL] [Abstract][Full Text] [Related]
7. Growth arrest by the antitumor steroidal lactone withaferin A in human breast cancer cells is associated with down-regulation and covalent binding at cysteine 303 of β-tubulin.
Antony ML; Lee J; Hahm ER; Kim SH; Marcus AI; Kumari V; Ji X; Yang Z; Vowell CL; Wipf P; Uechi GT; Yates NA; Romero G; Sarkar SN; Singh SV
J Biol Chem; 2014 Jan; 289(3):1852-65. PubMed ID: 24297176
[TBL] [Abstract][Full Text] [Related]
8. Withaferin A-induced apoptosis in human breast cancer cells is mediated by reactive oxygen species.
Hahm ER; Moura MB; Kelley EE; Van Houten B; Shiva S; Singh SV
PLoS One; 2011; 6(8):e23354. PubMed ID: 21853114
[TBL] [Abstract][Full Text] [Related]
9. Withaferin A causes activation of Notch2 and Notch4 in human breast cancer cells.
Lee J; Sehrawat A; Singh SV
Breast Cancer Res Treat; 2012 Nov; 136(1):45-56. PubMed ID: 22965833
[TBL] [Abstract][Full Text] [Related]
10. Withaferin A-induced apoptosis in human breast cancer cells is associated with suppression of inhibitor of apoptosis family protein expression.
Hahm ER; Singh SV
Cancer Lett; 2013 Jun; 334(1):101-8. PubMed ID: 22935676
[TBL] [Abstract][Full Text] [Related]
11. RNA-seq reveals novel cancer-selective and disease subtype-independent mechanistic targets of withaferin A in human breast cancer cells.
Hahm ER; Kim SH; Singh KB; Singh SV
Mol Carcinog; 2021 Jan; 60(1):3-14. PubMed ID: 33150660
[TBL] [Abstract][Full Text] [Related]
12. A Comprehensive Review and Perspective on Anticancer Mechanisms of Withaferin A in Breast Cancer.
Hahm ER; Kim SH; Singh KB; Singh K; Singh SV
Cancer Prev Res (Phila); 2020 Sep; 13(9):721-734. PubMed ID: 32727824
[TBL] [Abstract][Full Text] [Related]
13. Withania somnifera root extract inhibits mammary cancer metastasis and epithelial to mesenchymal transition.
Yang Z; Garcia A; Xu S; Powell DR; Vertino PM; Singh S; Marcus AI
PLoS One; 2013; 8(9):e75069. PubMed ID: 24069380
[TBL] [Abstract][Full Text] [Related]
14. Withaferin A inhibits expression of ataxia telangiectasia and Rad3-related kinase and enhances sensitivity of human breast cancer cells to cisplatin.
Hahm ER; Lee J; Abella T; Singh SV
Mol Carcinog; 2019 Nov; 58(11):2139-2148. PubMed ID: 31441116
[TBL] [Abstract][Full Text] [Related]
15. The Role of Forkhead Box Q1 Transcription Factor in Anticancer Effects of Withaferin A in Breast Cancer.
Kim SH; Singh KB; Hahm ER; Singh SV
Cancer Prev Res (Phila); 2021 Apr; 14(4):421-432. PubMed ID: 33509807
[TBL] [Abstract][Full Text] [Related]
16. The monoamine oxidase-A inhibitor clorgyline promotes a mesenchymal-to-epithelial transition in the MDA-MB-231 breast cancer cell line.
Satram-Maharaj T; Nyarko JN; Kuski K; Fehr K; Pennington PR; Truitt L; Freywald A; Lukong KE; Anderson DH; Mousseau DD
Cell Signal; 2014 Dec; 26(12):2621-32. PubMed ID: 25152370
[TBL] [Abstract][Full Text] [Related]
17. Withaferin A Inhibits Fatty Acid Synthesis in Rat Mammary Tumors.
Singh KB; Hahm ER; Kim SH; Singh SV
Cancer Prev Res (Phila); 2023 Jan; 16(1):5-16. PubMed ID: 36251722
[TBL] [Abstract][Full Text] [Related]
18. Mammary cancer chemoprevention by withaferin A is accompanied by in vivo suppression of self-renewal of cancer stem cells.
Kim SH; Singh SV
Cancer Prev Res (Phila); 2014 Jul; 7(7):738-47. PubMed ID: 24824039
[TBL] [Abstract][Full Text] [Related]
19. Peptidyl-prolyl cis/trans isomerase Pin1 regulates withaferin A-mediated cell cycle arrest in human breast cancer cells.
Samanta SK; Lee J; Hahm ER; Singh SV
Mol Carcinog; 2018 Jul; 57(7):936-946. PubMed ID: 29603395
[TBL] [Abstract][Full Text] [Related]
20. Resveratrol Inhibits the Migration and Metastasis of MDA-MB-231 Human Breast Cancer by Reversing TGF-β1-Induced Epithelial-Mesenchymal Transition.
Sun Y; Zhou QM; Lu YY; Zhang H; Chen QL; Zhao M; Su SB
Molecules; 2019 Mar; 24(6):. PubMed ID: 30901941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]